Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing somatropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 13.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.2mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.4mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.6mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.8mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.0mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.2mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.4mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.6mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 2mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5.0mg/1.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10.0mg/1.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 15mg/1.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10mg/2mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10mg/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.5mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.44mg/unit powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.6mg/unt powder (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.8mg/unt powder (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.2mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.4mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.6mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 1.8mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 2.0mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 12mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 6mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin (electron paramagnetic resonance) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin (relative biologic efficacy) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin (recombinant mouse cells) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 12mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 0.6mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 15mg/1.5mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5.0mg/1.5mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 6mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 10.0mg/1.5mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 4mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 8.8mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 13.5mg/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 18mg/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 22.5mg/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin(rbe) 5mg(15iu)/mL injection solution 2mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human growth hormone |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatrophic hormone adverse reaction |
Causative agent (attribute) |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to somatropin hormone (finding) |
Causative agent (attribute) |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatrem (substance) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sermorelin (substance) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatotropin challenge tests |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
45 minute serum growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Plasma growth hormone measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
90 minute plasma growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
60 minute plasma growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
30 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
120 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
30 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
60 minute serum growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
90 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
180 minute plasma growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
210 minute plasma growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
210 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
240 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
150 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
240 minute plasma GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
120 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
150 minute serum growth hormone measurement (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
180 minute serum GH measurement |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Urine growth hormone level (procedure) |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Somatropin 1.5mg powder for injection solution vial + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5.8mg powder for injection solution vial + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by somatotropin |
Causative agent (attribute) |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Somatotrophin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental somatotrophin poisoning |
Causative agent (attribute) |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional somatotrophin poisoning |
Causative agent (attribute) |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Somatropin 5mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucagon stimulation test |
Component |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to somatropin hormone (finding) |
Causative agent (attribute) |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Somatropin 1.5mg powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatropin 5.8mg powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing somatropin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sermorelin acetate (substance) |
Is a |
False |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only somatropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Somatropin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre pour solution injectable |
Has precise active ingredient |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre pour solution injectable |
Has basis of strength substance (attribute) |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Somatropin 10 mg/mL solution for injection |
Has precise active ingredient |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Somatropin 10 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Somatropin 4 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Somatropin 4 mg/mL solution for injection |
Has precise active ingredient |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning caused by somatropin (disorder) |
Causative agent (attribute) |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental somatropin poisoning |
Causative agent (attribute) |
True |
Somatropin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |